02/23/2026 | Press release | Distributed by Public on 02/23/2026 10:32
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-23494
T. Rowe Price Exchange-Traded Funds, Inc.
(Exact name of registrant as specified in charter)
1307 Point Street, Baltimore, MD 21231
(Address of principal executive offices)
David Oestreicher
1307 Point Street, Baltimore, MD 21231
(Name and address of agent for service)
Registrant's telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: December 31, 2025
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about Hedged Equity ETF (the "fund") for the period of March 26, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information at www.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or by contacting your intermediary.
|
Fund name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Hedged Equity ETF
|
$16
|
0.19%
|
Major U.S. stock indexes rose in 2025. After a challenging start to the year stemming from new U.S. tariffs, equities advanced as economic growth and corporate earnings remained favorable, investors favored artificial intelligence-related and other high-growth businesses, and Congress passed tax legislation that should help stimulate the economy. In addition, signs of a weakening labor market prompted the Federal Reserve to resume reducing short-term interest rates in the latter part of the year. The central bank lowered rates in September, October, and December.
Versus the S&P 500 Index, security selection within the U.S. Equity Research ETF contributed to relative results. The fund's equity index put options were also additive during the trailing 12 months.
The derivatives hedge that reduces the fund's net equity exposure detracted from relative results given the strong equity market throughout the year. The fund's exposure to U.S. lower-volatility equities further weighed on relative results.
The fund seeks capital appreciation by investing in U.S. large-cap equities while aiming to deliver a lower risk profile, especially during significant equity downturns, by investing in multiple tail risk mitigating strategies. The fund uses an approach to risk estimation that gives more weight to extreme negative returns.
The fund held material exposure to various types of derivatives, which are used to efficiently access or adjust exposure to certain market segments and/or to manage portfolio volatility. Exposure to these derivatives detracted from total returns.
|
ETF (Based on Net Asset Value)
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
3/26/25
|
10,000
|
10,000
|
10,000
|
|
6/2025
|
10,516
|
10,883
|
10,727
|
|
9/2025
|
11,140
|
11,773
|
11,484
|
|
12/2025
|
11,281
|
12,056
|
11,557
|
202505-4541202, 202601-5113267
ETF1177-052 02/26
|
Fund
|
Since Inception 3/26/25
|
|
Hedged Equity ETF (Based on Net Asset Value)
|
12.81%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
20.56%
|
|
CBOE S&P 500 5% Put Protection Index (Strategy Benchmark)
|
15.57%
|
The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any. Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Exchange-Traded Funds
|
80.5%
|
|
Information Technology
|
3.3
|
|
Financials
|
1.9
|
|
Health Care
|
1.8
|
|
Industrials & Business Services
|
1.0
|
|
Utilities
|
0.9
|
|
Consumer Staples
|
0.9
|
|
Consumer Discretionary
|
0.8
|
|
Communication Services
|
0.6
|
|
Other
|
8.3
|
|
T. Rowe Price U.S. Equity Research ETF
|
80.5%
|
|
McKesson
|
0.3
|
|
Chubb
|
0.3
|
|
Cencora
|
0.3
|
|
Microsoft
|
0.3
|
|
T-Mobile US
|
0.3
|
|
Mastercard
|
0.2
|
|
McDonald's
|
0.2
|
|
Duke Energy
|
0.2
|
|
ServiceNow
|
0.2
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosuresfor additional legal notices & disclaimers
Hedged Equity ETF (THEQ)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Principal Listing Exchange: NYSE Arca, Inc.
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR,applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR.No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.
Item 3. Audit Committee Financial Expert.
The registrant's Board of Directors has determined that Mr. Paul F. McBride qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR.Mr. McBride is considered independent for purposes of Item 3 of Form N-CSR.
Item 4. Principal Accountant Fees and Services.
(a) - (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant's principal accountant were as follows:
| 2025 | 2024 | |||||||||
|
Audit Fees |
$ | 28,847 | $- | |||||||
|
Audit-Related Fees |
- | - | ||||||||
|
Tax Fees |
- | - | ||||||||
|
All Other Fees |
- | - | ||||||||
Audit fees include amounts related to the audit of the registrant's annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant's financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant's pro-ratashare of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant's Board of Directors/Trustees.
(e)(1) The registrant's audit committee has adopted a policy whereby audit and non-auditservices performed by the registrant's principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approvalin advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approvalmay be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approvalfor audit or non-auditservices requiring fees of a de minimis amount is not permitted.
(2) No services included in (b) - (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01of Regulation S-X.
(f) Less than 50 percent of the hours expended on the principal accountant's engagement to audit the registrant's financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant's full-time, permanent employees.
(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant's principal accountant for non-auditservices rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,862,000 and $1,262,000, respectively.
(h) All non-auditservices rendered in (g) above were pre-approvedby the registrant's audit committee. Accordingly, these services were considered by the registrant's audit committee in maintaining the principal accountant's independence.
(i) Not applicable.
(j) Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-EndManagement Investment Companies.
(a - b) Report pursuant to Regulation S-X.
| T. ROWE PRICE | |
| THEQ | Hedged Equity ETF |
| For more insights from T. Rowe Price investment professionals, go totroweprice.com. |
|
3/26/25(1) Through |
|
| 12/31/25 | |
| NET ASSET VALUE | |
| Beginning of period | $ 25.00 |
| Investment activities | |
| Net investment income(2)(3) | 0.30 |
| Net realized and unrealized gain/loss | 2.90 |
| Total from investment activities | 3.20 |
| Distributions | |
| Net investment income | (0.14) |
| Net realized gain | (0.08) |
| Total distributions | (0.22) |
| NET ASSET VALUE | |
| End of period | $ 27.98 |
|
3/26/25(1) Through |
|
| 12/31/25 | |
| Ratios/Supplemental Data | |
| Total return, based on NAV(3)(4)(5) | 12.81% |
|
Ratios to average net assets:(3)(4) |
|
|
Gross expenses before waivers/payments by Price Associates |
0.46%(6) |
|
Net expenses after waivers/payments by Price Associates |
0.19%(6) |
| Net investment income | 1.45%(6) |
| Portfolio turnover rate(4)(7) | 15.3% |
|
Net assets, end of period (in thousands) |
$ 34,272 |
| (1) | Inception date |
| (2) | Per share amounts calculated using average shares outstanding method. |
| (3) | Includes the impact of expense-related arrangements with Price Associates. |
| (4) | Reflects the activity of the fund, and does not include the activity of the underlying funds. However, investment performance of the fund is directly related to the investment performance of the underlying funds in which it invests. |
| (5) | Total return reflects the rate that an investor would have earned on an investment in the fund during the period, assuming reinvestment of all distributions. Total return is not annualized for periods less than one year.The fund's total return may be higher or lower than the investment results of the individual underlying funds. |
| (6) | Annualized |
| (7) | Portfolio turnover excludes securities received or delivered through in-kind share transactions. |
| PORTFOLIO OF INVESTMENTS‡ | Shares/Par | $ Value |
| (Cost and value in $000s) | ||
| COMMON STOCKS 11.8% | ||
| COMMUNICATION SERVICES 0.6% | ||
| Diversified Telecommunication Services 0.3% | ||
| AT&T | 1,324 | 33 |
| Verizon Communications | 1,325 | 54 |
| 87 | ||
| Entertainment 0.0% | ||
| Electronic Arts | 90 | 18 |
| 18 | ||
| Wireless Telecommunication Services 0.3% | ||
| T-Mobile US | 442 | 90 |
| 90 | ||
| Total Communication Services | 195 | |
| CONSUMER DISCRETIONARY 0.8% | ||
| Hotels, Restaurants & Leisure 0.3% | ||
| Booking Holdings | 1 | 5 |
| Domino's Pizza | 14 | 6 |
| McDonald's | 252 | 77 |
| Yum! Brands | 58 | 9 |
| 97 | ||
| Specialty Retail 0.5% | ||
| AutoZone (1) | 13 | 44 |
| Home Depot | 16 | 6 |
| Lowe's | 143 | 34 |
| O'Reilly Automotive (1) | 546 | 50 |
| TJX | 209 | 32 |
| 166 | ||
| Total Consumer Discretionary | 263 | |
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| CONSUMER STAPLES 0.9% | ||
| Beverages 0.1% | ||
| Keurig Dr Pepper | 675 | 19 |
| PepsiCo | 155 | 22 |
| 41 | ||
| Consumer Staples Distribution & Retail 0.1% | ||
| Walmart | 180 | 20 |
| 20 | ||
| Food Products 0.1% | ||
| General Mills | 443 | 21 |
| Ingredion | 233 | 26 |
| 47 | ||
| Household Products 0.4% | ||
| Colgate-Palmolive | 834 | 66 |
| Procter & Gamble | 484 | 69 |
| 135 | ||
| Tobacco 0.2% | ||
| Philip Morris International | 348 | 56 |
| 56 | ||
| Total Consumer Staples | 299 | |
| ENERGY 0.5% | ||
| Oil, Gas & Consumable Fuels 0.5% | ||
| ConocoPhillips | 340 | 32 |
| EOG Resources | 347 | 36 |
| Exxon Mobil | 597 | 72 |
| Williams | 353 | 21 |
| Total Energy | 161 | |
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| FINANCIALS 1.9% | ||
| Capital Markets 0.3% | ||
| Cboe Global Markets | 162 | 41 |
| CME Group | 249 | 68 |
| 109 | ||
| Financial Services 0.6% | ||
| Berkshire Hathaway, Class B (1) | 105 | 53 |
| Mastercard, Class A | 141 | 80 |
| Visa, Class A | 199 | 70 |
| 203 | ||
| Insurance 1.0% | ||
| Allstate | 255 | 53 |
| Arthur J. Gallagher | 38 | 10 |
| Chubb | 333 | 104 |
| Hartford Insurance Group | 309 | 42 |
| Marsh & McLennan | 244 | 45 |
| Progressive | 145 | 33 |
| RenaissanceRe Holdings | 102 | 29 |
| Travelers | 86 | 25 |
| 341 | ||
| Total Financials | 653 | |
| HEALTH CARE 1.8% | ||
| Biotechnology 0.4% | ||
| AbbVie | 109 | 25 |
| Gilead Sciences | 555 | 68 |
| Regeneron Pharmaceuticals | 35 | 27 |
| United Therapeutics (1) | 37 | 18 |
| Vertex Pharmaceuticals (1) | 6 | 3 |
| 141 | ||
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| Health Care Equipment & Supplies 0.3% | ||
| Becton Dickinson & Company | 59 | 11 |
| Medtronic | 352 | 34 |
| ResMed | 112 | 27 |
| Zimmer Biomet Holdings | 237 | 21 |
| 93 | ||
| Health Care Providers & Services 0.7% | ||
| Cencora | 288 | 97 |
| Encompass Health | 159 | 17 |
| McKesson | 137 | 113 |
| UnitedHealth Group | 88 | 29 |
| 256 | ||
| Pharmaceuticals 0.4% | ||
| Eli Lilly | 9 | 10 |
| Johnson & Johnson | 306 | 63 |
| Merck | 668 | 70 |
| 143 | ||
| Total Health Care | 633 | |
| INDUSTRIALS & BUSINESS SERVICES 1.0% | ||
| Aerospace & Defense 0.2% | ||
| Lockheed Martin | 62 | 30 |
| Northrop Grumman | 44 | 25 |
| 55 | ||
| Commercial Services & Supplies 0.4% | ||
| Republic Services | 203 | 43 |
| Waste Connections | 329 | 58 |
| Waste Management | 191 | 42 |
| 143 | ||
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| Electrical Equipment 0.0% | ||
| AMETEK | 51 | 10 |
| 10 | ||
| Ground Transportation 0.0% | ||
| CSX | 305 | 11 |
| 11 | ||
| Machinery 0.0% | ||
| Parker-Hannifin | 8 | 7 |
| 7 | ||
| Professional Services 0.4% | ||
| Automatic Data Processing | 95 | 24 |
| Booz Allen Hamilton | 290 | 25 |
| Broadridge Financial Solutions | 53 | 12 |
| SS&C Technologies Holdings | 302 | 26 |
| Verisk Analytics | 138 | 31 |
| 118 | ||
| Total Industrials & Business Services | 344 | |
| INFORMATION TECHNOLOGY 3.3% | ||
| Communications Equipment 0.5% | ||
| Arista Networks (1) | 53 | 7 |
| Cisco Systems | 867 | 67 |
| F5 (1) | 113 | 29 |
| Motorola Solutions | 150 | 57 |
| 160 | ||
| Electronic Equipment, Instruments & Components 0.4% | ||
| Amphenol, Class A | 399 | 54 |
| TE Connectivity | 202 | 46 |
| Teledyne Technologies (1) | 112 | 57 |
| 157 | ||
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| IT Services 0.7% | ||
| Accenture, Class A | 202 | 54 |
| Amdocs | 289 | 23 |
| Cognizant Technology Solutions, Class A | 682 | 57 |
| GoDaddy, Class A (1) | 210 | 26 |
| International Business Machines | 150 | 45 |
| VeriSign | 136 | 33 |
| 238 | ||
| Semiconductors & Semiconductor Equipment 0.2% | ||
| NVIDIA | 211 | 39 |
| QUALCOMM | 99 | 17 |
| Texas Instruments | 55 | 10 |
| 66 | ||
| Software 1.4% | ||
| Cadence Design Systems (1) | 57 | 18 |
| Check Point Software Technologies (1) | 133 | 25 |
| Fortinet (1) | 436 | 35 |
| Intuit | 101 | 67 |
| Microsoft | 195 | 94 |
| Oracle | 14 | 3 |
| Palo Alto Networks (1) | 203 | 37 |
| PTC (1) | 230 | 40 |
| Roper Technologies | 108 | 48 |
| Salesforce.com | 107 | 28 |
| ServiceNow (1) | 478 | 73 |
| Workday (1) | 52 | 11 |
| 479 | ||
| Technology Hardware, Storage & Peripherals 0.1% | ||
| Apple | 44 | 12 |
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| NetApp | 285 | 30 |
| 42 | ||
| Total Information Technology | 1,142 | |
| MATERIALS 0.1% | ||
| Chemicals 0.1% | ||
| Linde | 59 | 25 |
| 25 | ||
| Metals & Mining 0.0% | ||
| Newmont | 113 | 12 |
| 12 | ||
| Total Materials | 37 | |
| UTILITIES 0.9% | ||
| Electric Utilities 0.5% | ||
| Duke Energy | 648 | 76 |
| Entergy | 101 | 9 |
| Evergy | 439 | 32 |
| Southern | 403 | 35 |
| Xcel Energy | 452 | 34 |
| 186 | ||
| Gas Utilities 0.0% | ||
| Atmos Energy | 102 | 17 |
| 17 | ||
| Multi-Utilities 0.4% | ||
| Ameren | 303 | 30 |
| CMS Energy | 553 | 39 |
| Consolidated Edison | 185 | 18 |
| DTE Energy | 208 | 27 |
| Shares/Par | $ Value | |
| (Cost and value in $000s) | ||
| WEC Energy Group | 53 | 6 |
| 120 | ||
| Total Utilities | 323 | |
| Total Common Stocks (Cost $4,060) | 4,050 | |
| EXCHANGE-TRADED FUNDS 80.5% | ||
| Exchange-Traded Funds 80.5% | ||
| T. Rowe Price U.S. Equity Research ETF (2) | 644,777 | 27,584 |
| Total Exchange-Traded Funds (Cost $24,957) | 27,584 | |
| SHORT-TERM INVESTMENTS 7.4% | ||
| Money Market Funds 6.4% | ||
| T. Rowe Price Government Reserve Fund, 3.77% (2)(3) | 2,204,173 | 2,204 |
| U.S. Treasury Obligations 1.0% | ||
| U.S. Treasury Bills, 3.90%, 1/8/26 | 40,000 | 40 |
| U.S. Treasury Bills, 3.80%, 2/12/26 (4) | 20,000 | 20 |
| U.S. Treasury Bills, 3.85%, 1/22/26 (4) | 90,000 | 90 |
| U.S. Treasury Bills, 3.77%, 2/19/26 (4) | 160,000 | 159 |
| U.S. Treasury Bills, 3.81%, 1/27/26 (4) | 20,000 | 20 |
| 329 | ||
| Total Short-Term Investments (Cost $2,533) | 2,533 | |
| OPTIONS PURCHASED 0.3% | ||||
| Exchange-Traded Options Purchased 0.2% |
| Description | Contracts | Notional Amount | $ Value | |
| S&P 500 Index, Put, 10/16/26 @ $5,900 (1) | 2 | 1,369 | 28 | |
| S&P 500 Index, Put, 11/20/26 @ $5,900 (1) | 2 | 1,369 | 31 | |
| Total Exchange-Traded Options Purchased (Cost $74) | 59 | |||
| OTC Options Purchased 0.1% |
| Counterparty | Description | Contracts | Notional Amount | $ Value |
| Morgan Stanley | S&P 500 Index, Put, 12/18/26 @ $6,000 (1) | 2 | 1,369 | 37 |
| Total OTC Options Purchased (Cost $39) | 37 | |||
| Total Options Purchased (Cost $113) | 96 | |||
|
Total Investments in Securities 100.0% of Net Assets (Cost $31,663) |
$34,263 |
| ‡ | Shares/Par and Notional Amount are denominated in U.S. dollars unless otherwise noted. |
| (1) | Non-income producing. |
| (2) | The underlying fund is an affiliated company. Additional information about the underlying fund including the financial statements and portfolio holdings is available by calling 1-877-495-1138 and at www.troweprice.com. |
| (3) | Seven-day yield |
| (4) | At December 31, 2025, all or a portion of this security is pledged as collateral and/or margin deposit to cover future funding obligations. |
| ETF | Exchange-Traded Fund |
| OTC | Over-the-counter |
| FUTURES CONTRACTS |
| ($000s) |
|
Expiration Date |
Notional Amount |
Value and Unrealized Gain (Loss) |
|
| Short, 5 E-mini S&P 500 contracts | 03/26 | (1,722) | $(1) |
| Long, 38 U.S. Treasury Notes ten year contracts | 03/26 | 4,295 | (22) |
| Net payments (receipts) of variation margin to date | 28 | ||
| Variation margin receivable (payable) on open futures contracts | $5 | ||
| Affiliate |
Net Realized Gain (Loss) |
Changes in Net Unrealized Gain/Loss |
Investment Income |
| T. Rowe Price U.S. Equity Research ETF | $162 | $2,627 | $172 |
| T. Rowe Price Treasury Reserve Fund | - | - | 32++ |
| T. Rowe Price Government Reserve Fund | - | - | 8++ |
| Totals | $162# | $2,627 | $212+ |
| Supplementary Investment Schedule | ||||
| Affiliate |
Value 12/31/24 |
Purchase Cost |
Sales Cost |
Value 12/31/25 |
| T. Rowe Price U.S. Equity Research ETF | $- | 26,995 | 2,038 | $27,584 |
| T. Rowe Price Treasury Reserve Fund | - | ¤ | ¤ | - |
| T. Rowe Price Government Reserve Fund | - | ¤ | ¤ | 2,204 |
| Total | $29,788^ | |||
| ++ | Excludes earnings on securities lending collateral, which are subject to rebates and fees as described in Note 4. |
| # | Capital gain distributions from underlying funds represented $0 of the net realized gain (loss). |
| + | Investment income comprised $212 of dividend income and $0 of interest income. |
| ¤ | Purchase and sale information not shown for cash management funds. |
| ^ | The cost basis of investments in affiliated companies was $27,161. |
| Assets | |
| Investments in securities, at value (cost $31,663) | $34,263 |
| Dividends receivable | 8 |
| Variation margin receivable on futures contracts | 5 |
| Total assets | 34,276 |
| Liabilities | |
| Investment management and administrative fees payable | 4 |
| Total liabilities | 4 |
| NET ASSETS | $34,272 |
| Net Assets Consists of: | |
| Total distributable earnings (loss) | $2,088 |
|
Paid-in capital applicable to 1,225,000 shares of $0.0001 par value capital stock outstanding; 4,000,000,000 shares of the Corporation authorized |
32,184 |
| NET ASSETS | $34,272 |
| NET ASSET VALUE PER SHARE | $27.98 |
|
3/26/25 Through |
|
| 12/31/25 | |
| Investment Income (Loss) | |
| Income | |
| Dividend | $242 |
| Interest | 12 |
| Securities lending | 4 |
| Total income | 258 |
| Expenses | |
| Investment management and administrative expense | 72 |
| Waived / paid by Price Associates | (43) |
| Total expenses | 29 |
| Net investment income | 229 |
| Realized and Unrealized Gain / Loss | |
| Net realized gain (loss) | |
| Securities | (29) |
| In-kind redemptions | 128 |
| Futures | (552) |
| Net realized loss | (453) |
| Change in net unrealized gain / loss | |
| Securities | 2,600 |
| Futures | (23) |
| Change in unrealized gain / loss | 2,577 |
| Net realized and unrealized gain / loss | 2,124 |
| INCREASE IN NET ASSETS FROM OPERATIONS | $2,353 |
|
3/26/25 Through |
|
| 12/31/25 | |
| Increase (Decrease) in Net Assets | |
| Operations | |
| Net investment income | $229 |
| Net realized loss | (453) |
| Change in net unrealized gain / loss | 2,577 |
| Increase in net assets from operations | 2,353 |
| Distributions to shareholders | |
| Net earnings | (272) |
| Capital share transactions* | |
| Shares sold | 32,873 |
| Shares redeemed | (682) |
| Increase in net assets from capital share transactions | 32,191 |
| Net Assets | |
| Increase during period | 34,272 |
| Beginning of period | - |
| End of period | $34,272 |
| *Share information (000s) | |
| Shares sold | 1,250 |
| Shares redeemed | (25) |
| Increase in shares outstanding | 1,225 |
| ($000s) | Level 1 | Level 2 | Level 3 | Total Value |
| Assets | ||||
| Common Stocks | $4,050 | $- | $- | $4,050 |
| Exchange-Traded Funds | 27,584 | - | - | 27,584 |
| Short-Term Investments | 2,204 | 329 | - | 2,533 |
| Options Purchased | - | 96 | - | 96 |
| Total | $33,838 | $425 | $- | $34,263 |
| Liabilities | ||||
| Futures Contracts* | $23 | $- | $- | $23 |
| * | The fair value presented includes cumulative gain (loss) on open futures contracts; however, the net value reflected on the accompanying Portfolio of Investments is only the unsettled variation margin receivable (payable) at that date. |
| ($000s) |
Location on Statement of Assets and Liabilities |
Fair Value* |
| Assets | ||
| Equity derivatives | Securities^ | $96 |
| Liabilities | ||
| Interest rate derivatives | Futures | $22 |
| Equity derivatives | Futures | 1 |
| Total | $23 |
| * | The fair value presented includes cumulative gain (loss) on open futures contracts; however, the value reflected on the accompanying Statement of Assets and Liabilities is only the unsettled variation margin receivable (payable) at that date. |
| ^ | Options purchased are reported as securities and are reflected in the accompanying Portfolio of Investments. |
| (000s) Location of Gain (Loss) on Statement of Operations | |||
| Securities^ | Futures | Total | |
|
Realized Gain (Loss) |
|||
|
Interest rate derivatives |
$- | $66 | $66 |
| Equity derivatives | (50) | (618) | (668) |
| Total | $(50) | $(552) | $(602) |
|
Change in Unrealized Gain (Loss) |
|||
|
Interest rate derivatives |
$- | $(22) | $(22) |
| Equity derivatives | (17) | (1) | (18) |
| Total | $(17) | $(23) | $(40) |
| ^ | Options purchased are reported as securities. |
| ($000s) | |
| December 31, | |
| 2025 | |
| Ordinary income (including short-term capital gains, if any) | $243 |
| Long-term capital gain | 29 |
| Total distributions | $272 |
| ($000s) | |
| Cost of investments | $32,237 |
| Unrealized appreciation | $2,769 |
| Unrealized depreciation | (743) |
| Net unrealized appreciation (depreciation) | $2,026 |
| ($000s) | |
| Undistributed ordinary income | $65 |
| Net unrealized appreciation (depreciation) | 2,026 |
| Loss carryforwards and deferrals | (3) |
| Total distributable earnings (loss) | $2,088 |
| (000s) |
Effective Management Fee Rate |
Management Fee Waived |
| T. Rowe Price U.S. Equity Research ETF | 0.34% | $43 |
Item 8. Changes in and Disagreements with Accountants for Open-EndManagement Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-EndManagement Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-EndManagement Investment Companies.
Remuneration paid to Directors is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
If applicable, see Item 7.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-EndManagement Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-EndManagement Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-EndManagement Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant's board of directors.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer have evaluated the registrant's disclosure controls and procedures within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSRwas recorded, processed, summarized, and reported timely.
(b) The registrant's principal executive officer and principal financial officer are aware of no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-EndManagement Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
| (a)(1) |
N-CSR |
|
| (2) |
Listing standards relating to recovery of erroneously awarded compensation: not applicable. |
|
| (3) |
30a-2(a) |
|
| (b) |
30a-2(b) |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| T. Rowe Price Exchange-Traded Funds, Inc. | ||||
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date | February 18, 2026 | |||
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date |
February 18, 2026 |
|||
| By |
/s/ Alan S. Dupski |
|||
| Alan S. Dupski | ||||
| Principal Financial Officer | ||||
| Date |
February 18, 2026 |
|||